|
Volumn 26, Issue 6, 2014, Pages 783-784
|
Treating Transcriptional Addiction in Small Cell Lung Cancer
a
USA
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CISPLATIN;
CYCLIN DEPENDENT KINASE 7;
ETOPOSIDE;
INSM1 PROTEIN;
MYC PROTEIN;
NEUROGENIC DIFFERENTIATION FACTOR;
PROTEIN;
RNA POLYMERASE II;
TRANSCRIPTION FACTOR;
TRANSCRIPTION FACTOR MASH1;
TRANSCRIPTION FACTOR SOX2;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC AGENT;
ENZYME INHIBITOR;
BINDING SITE;
CANCER CELL;
CANCER CHEMOTHERAPY;
CARBOXY TERMINAL SEQUENCE;
CHEMOSENSITIVITY;
GENETICALLY ENGINEERED MOUSE STRAIN;
HUMAN;
NONHUMAN;
SHORT SURVEY;
SMALL CELL LUNG CANCER;
TRANSCRIPTION INITIATION;
TUMOR GROWTH;
TUMOR REGRESSION;
TUMOR VOLUME;
ANIMAL;
DRUG EFFECTS;
GENE EXPRESSION REGULATION;
GENETICS;
LUNG NEOPLASMS;
METABOLISM;
ANIMALS;
ANTINEOPLASTIC AGENTS;
ENZYME INHIBITORS;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
LUNG NEOPLASMS;
TRANSCRIPTION FACTORS;
|
EID: 84919491330
PISSN: 15356108
EISSN: 18783686
Source Type: Journal
DOI: 10.1016/j.ccell.2014.11.012 Document Type: Short Survey |
Times cited : (20)
|
References (10)
|